Co-Authors
This is a "connection" page, showing publications co-authored by Awad Al-Omari and Fahad Al-Hameed.
Connection Strength
0.529
-
Critically ill patients with diabetes and Middle East respiratory syndrome: a multi-center observational study. BMC Infect Dis. 2021 Jan 19; 21(1):84.
Score: 0.058
-
Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study. Clin Infect Dis. 2020 04 15; 70(9):1837-1844.
Score: 0.055
-
Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome. Influenza Other Respir Viruses. 2019 07; 13(4):382-390.
Score: 0.051
-
Macrolides in critically ill patients with Middle East Respiratory Syndrome. Int J Infect Dis. 2019 Apr; 81:184-190.
Score: 0.050
-
Critically ill healthcare workers with the middle east respiratory syndrome (MERS): A multicenter study. PLoS One. 2018; 13(11):e0206831.
Score: 0.050
-
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome. Am J Respir Crit Care Med. 2018 03 15; 197(6):757-767.
Score: 0.047
-
Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care. 2018 Jan 10; 8(1):3.
Score: 0.047
-
Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study. Crit Care Med. 2017 10; 45(10):1683-1695.
Score: 0.046
-
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia. Emerg Infect Dis. 2016 09; 22(9):1554-61.
Score: 0.043
-
Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians. BMC Anesthesiol. 2016 07 12; 16(1):36.
Score: 0.042
-
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. Springerplus. 2015; 4:709.
Score: 0.040